Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell Beloud

@wfmz.com · 1 hour

Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell

Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell

A new study published in Cancer Cell by Kelun-Biotech researchers reveals that combining the antibody-drug conjugate sacituzumab tirumotecan (sac-TMT) with the EGFR-TKI osimertinib shows pro...

Read more Wfmz.com